Connors Investor Services Inc. Sells 737 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Connors Investor Services Inc. cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 32,815 shares of the company’s stock after selling 737 shares during the quarter. Connors Investor Services Inc.’s holdings in Prestige Consumer Healthcare were worth $2,563,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PBH. Kayne Anderson Rudnick Investment Management LLC bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $84,932,000. Raymond James Financial Inc. bought a new position in Prestige Consumer Healthcare in the fourth quarter valued at approximately $42,593,000. Norges Bank bought a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $40,009,000. Bessemer Group Inc. boosted its stake in Prestige Consumer Healthcare by 10,053.1% in the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company’s stock worth $23,041,000 after purchasing an additional 292,144 shares during the period. Finally, Boston Trust Walden Corp boosted its position in shares of Prestige Consumer Healthcare by 43.5% during the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock worth $64,942,000 after buying an additional 252,089 shares during the period. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Royal Bank of Canada raised their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a report on Friday, March 21st. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday. Oppenheimer lifted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Finally, DA Davidson upped their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $93.33.

Insider Activity

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Trading Up 1.3 %

Shares of PBH stock opened at $82.01 on Wednesday. The company has a market cap of $4.06 billion, a P/E ratio of 19.20, a PEG ratio of 2.69 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $90.04. The stock has a 50 day simple moving average of $83.46 and a two-hundred day simple moving average of $80.73. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.